Without insurance, compounded semaglutide typically costs roughly $150–$500 a month across licensed US telehealth providers, depending on the dose, the pharmacy, and how much clinical care is bundled into the price. At Pallas, pricing is one flat number with care included: compounded semaglutide injection is $139 for your first month, then $597 every 12 weeks ($199/mo average). Cancel anytime. That average — $199/mo — includes your US-licensed provider, ongoing check-ins, dose adjustments, and shipping, with no separate membership fee.
The short answer
Compounded semaglutide injection at Pallas is $139 for your first month, then $597 every 12 weeks ($199/mo average). Cancel anytime. The price stays the same at every dose, and it includes provider care and free shipping. No insurance is required — or accepted — because compounded plans are cash-pay.
What compounded semaglutide costs at Pallas
| Plan | Price |
|---|---|
| Semaglutide injection — first month | $139 |
| Then every 12 weeks | $597 |
| Per-month average | $199/mo |
| Oral semaglutide tablet (monthly) | $299/mo |
| Microdose semaglutide injection (monthly) | $179/mo |
To be precise about how the injection plan bills: it's $139 for your first month, then $597 every 12 weeks ($199/mo average). Cancel anytime. There is no signup fee, no per-visit charge, and the price does not increase as your dose is titrated up. If a clinician determines treatment isn't appropriate for you, you're refunded in full.
Prefer tirzepatide? Compounded tirzepatide injection is $179 for your first month, then $897 every 12 weeks ($299/mo average). Cancel anytime. Our semaglutide vs tirzepatide comparison walks through how the two differ.
Compounded medications are prepared on a per-patient basis by US-licensed compounding pharmacies, regulated under federal law (FDCA §503A) and by state boards of pharmacy. While these pharmacies are highly regulated, the compounded medications themselves are not FDA-approved, are not generic versions of brand-name drugs, and have not been evaluated by the FDA for safety, efficacy, or quality. Clinical trial outcomes for the FDA-approved products have not been established for compounded preparations. Individual results vary.
What's included in the price
A useful way to evaluate any GLP-1 price is to ask what it actually buys. At Pallas, the plan price covers:
- A US-licensed provider. Your intake is reviewed by a clinician licensed in your state, and prescriptions are written only when treatment is clinically appropriate. Eligibility is determined by a US-licensed clinician.
- Ongoing care, not just the first visit. Dose adjustments, check-ins, and unlimited care-team messaging are part of the plan — there's no fee each time you ask a question.
- The medication and shipping. Medication is prepared by US-licensed compounding pharmacies and ships free to your door.
- Flat pricing at every dose. Some programs charge more as your dose increases; Pallas compounded plans cost the same at a starting dose and at maintenance.
- Cancel anytime, refund if declined. Canceling is self-serve in the patient portal, and if a clinician doesn't approve treatment you're refunded in full.
Ready to see if you qualify?
A licensed Pallas provider can review your health history and confirm eligibility in under 2 minutes.
Start your intake →Why prices vary so much between providers
Two providers can both advertise "semaglutide" at very different monthly numbers and both be telling the truth — the difference is usually in the structure. When you're comparing, check four things:
- Is there a membership fee on top of the medication price? Many telehealth programs charge a recurring platform or membership fee plus a separate medication charge. The advertised number is often just one of the two.
- Does the price climb with your dose? Dose-based pricing is common, and semaglutide titration means most patients don't stay at the starting dose. A price that looks low at 0.25 mg can look very different at maintenance.
- What clinical care is included? Some low headline prices cover medication only, with visits, dose changes, or messaging billed separately.
- Is the renewal price the same as the first-month price? Introductory pricing is fine — as long as the renewal amount and billing interval are stated clearly next to it. If you can't find the renewal terms, that's a red flag in itself.
How does compounded semaglutide compare to brand-name prices?
Brand-name semaglutide — Wegovy® and Ozempic® (Novo Nordisk) — is also available through Pallas on a cash-pay basis when clinically appropriate, alongside the brand-name tirzepatide products from Eli Lilly. Brand-name medications dispensed through Pallas are cash-pay only and are not billed to insurance.
| Brand-name medication (at Pallas, cash-pay) | Monthly price |
|---|---|
| Wegovy® (semaglutide) | $1,349/mo |
| Ozempic® (semaglutide) | $1,299/mo |
| Zepbound® (tirzepatide) | $1,069/mo |
| Mounjaro® (tirzepatide) | $1,349/mo |
Why the large gap between compounded and brand-name pricing? They travel entirely different regulatory paths. Brand-name products are FDA-approved medicines manufactured at commercial scale, with pricing set by the manufacturer. Compounded preparations are prepared per-patient by US-licensed compounding pharmacies under FDCA §503A, prescribed when a licensed clinician documents a patient-specific clinical rationale. The lower price reflects that different pathway — it is not a discount on the brand product, and compounded preparations are not generic versions of Wegovy® or Ozempic®.
Does insurance cover compounded semaglutide?
No. Insurance does not cover compounded semaglutide — plans only cover FDA-approved products, and even for brand-name Wegovy®, coverage for weight management is inconsistent from plan to plan. Medicare is prohibited by law from covering medications prescribed for weight loss. That's why compounded semaglutide is priced for cash-pay from the start: the number you see is the whole number.
A note on pre-tax dollars: some patients use HSA or FSA funds toward weight-management care, which typically requires a Letter of Medical Necessity from a clinician — check your plan administrator's rules before assuming eligibility.
If a price looks too good to be true
Below a certain point, a low price stops being a bargain and starts being a warning sign. Skip any source that:
- Sells without a prescription. Semaglutide is a prescription medication. Any site that ships it without a clinician's review is operating outside the law.
- Labels vials "for research use only." Research-grade chemicals are not pharmaceutical products, are not prepared for human use, and are not dispensed by licensed pharmacies.
- Won't name its pharmacy. A legitimate provider can tell you which US-licensed pharmacy prepares and dispenses your medication.
- Has no verifiable certification. LegitScript maintains a public database of certified healthcare merchants — Pallas is LegitScript-certified, and you can look up any provider before paying them.
The safest structure is the boring one: a licensed clinician who reviews your health history, a named US-licensed pharmacy, and pricing with the renewal terms in plain sight.
The bottom line
Compounded semaglutide is one of the most affordable ways to start clinician-supervised GLP-1 treatment: at Pallas it averages $199/mo with provider care, dose adjustments, and shipping included, and the price never rises with your dose. Availability and telehealth rules vary slightly by state — find yours in our state-by-state GLP-1 directory, or read more about the full GLP-1 program.
Frequently asked questions
Across licensed US telehealth providers, compounded semaglutide typically runs roughly $150–$500 a month depending on the dose and what's bundled into the price. At Pallas, compounded semaglutide injection is $139 for your first month, then $597 every 12 weeks ($199/mo average). Cancel anytime. That price includes your US-licensed provider, ongoing check-ins, dose adjustments, care-team messaging, and free shipping — there's no separate membership fee, and no insurance is required. The compounded oral semaglutide tablet is $299/month.
Because they travel different regulatory paths. Wegovy® and Ozempic® are FDA-approved products manufactured by Novo Nordisk at commercial scale, with manufacturer-set pricing. Compounded semaglutide is prepared per-patient by US-licensed compounding pharmacies under FDCA §503A when a licensed clinician documents a patient-specific clinical rationale. The lower price reflects that different pathway — it is not a discount on the brand product, and compounded preparations are distinct per-patient preparations, not generic versions of the brand-name drugs.
Not at Pallas. Compounded plans cost the same at every dose — starting dose or maintenance. Dose-based pricing is common elsewhere in telehealth, and because semaglutide is titrated upward over the first months, a price that looks low at the starting dose can grow substantially. Always check what the maintenance dose costs before comparing programs.
No. Insurance plans only cover FDA-approved products, so compounded semaglutide is always cash-pay. Coverage for brand-name Wegovy® for weight management varies widely by plan, and Medicare is prohibited by law from covering medications prescribed for weight loss. Some patients apply HSA or FSA funds toward weight-management care, which typically requires a Letter of Medical Necessity — check your plan administrator's rules.
Not at Pallas. The plan price includes the clinician visit, prescriptions when clinically appropriate, dose adjustments, care-team messaging, and free shipping, with no separate membership fee. You can cancel anytime through the patient portal, and if a clinician determines treatment isn't appropriate for you, you're refunded in full.
No. Vials sold without a prescription or labeled 'for research use only' are not pharmaceutical products prepared for human use and are not dispensed by licensed pharmacies. Semaglutide is a prescription medication — a legitimate provider will always involve a US-licensed clinician's review and can name the US-licensed pharmacy that prepares your medication. You can verify any telehealth provider in LegitScript's public certification database.
At Pallas, compounded tirzepatide injection is $179 for your first month, then $897 every 12 weeks ($299/mo average). Cancel anytime. Like the semaglutide plan, it includes provider care, dose adjustments, and free shipping with no membership fee. Tirzepatide plans are priced higher than semaglutide plans; which medication fits you better is a clinical decision made with your provider.
See your price in about 2 minutes
Complete a quick health questionnaire and a US-licensed clinician will review whether treatment is appropriate for you. No insurance needed, no membership fee, cancel anytime.
Start your intake →Trademarks & disclosures
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk. Zepbound® and Mounjaro® are registered trademarks of Eli Lilly and Company. Pallas is not affiliated with, endorsed by, or sponsored by either manufacturer. Brand-name GLP-1 medications dispensed through Pallas are cash-pay only and are not billed to insurance. Prescriptions are written only when a US-licensed clinician determines treatment is appropriate.